News & Perspective

Feb 01, 2019

Feb 01, 2019

ASP Scan (Weekly) for Feb 01, 2019

Animal stewardship partnership
Antibiotic pipeline details
New PACCARB members
Decline in UK antibiotics
Superbug bloodstream infections in Greece
Antibiotics and malaria prevention
Promising antifungal candidate
Proposed UN AMR guidance
Proposed UN AMR guidance
Antibiotic use in nursing homes
Novel antibiotic vs C diff
Pharmacist interventions
Antibiotics for asthma attack

Mar 30, 2018

Mar 30, 2018

ASP Scan (Weekly) for Mar 30, 2018

Statewide hospital stewardship
New class of synthetic antibiotics
Candida auris in Europe
Experimental C diff drug
Urine culture and prescribing
MRSA, VRE contact precautions
Resistant Acinetobacter in SE Asia
Infection prevention and antibiotic stewardship
Cornerstones of stewardship
Resistant Acinetobacter in kids
C diff prediction tool
Perceived AMR risk in Germany

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

Mar 15, 2013

Mar 15, 2013

US flu markers show further signs of decline

(CIDRAP News) – Flu activity in the United States last week continued its slow retreat, with more areas of the country returning to regional baselines and fewer respiratory samples testing positive for the virus.

Mar 08, 2013

Mar 08, 2013

US flu activity almost back to baseline

(CIDRAP News) – Influenza activity in the United States continued to tumble last week, with one key marker—clinic visits for flulike illness—nearly approaching the national baseline, the US Centers for Disease Control and Prevention (CDC) said today.

Feb 22, 2013

Feb 22, 2013

Flu activity continues its slow retreat

(CIDRAP News) – Some of the key markers that US officials use to track flu continued to tumble last week, though activity was still elevated in most parts of the country, according to the Centers for Disease Control and Prevention (CDC) today.

Nationally, the percentage of doctors visits for flulike illness fell from 3.2% to 2.8% last week, with all parts of the country still above regional baselines.

Feb 15, 2013

Feb 15, 2013

CDC: Flu activity continues to slow

(CIDRAP News) – The nation's flu markers show that the flu has probably peaked, though many states are still reporting plenty of infections and hospitalizations, the US Centers for Disease Control and Prevention (CDC) said today.

Though the percentage of doctors' visits for influenza-like illness (ILI) is still above baselines in all regions of the country, the overall national level fell from 3.6% to 3.2% last week, according to the CDC.

Feb 14, 2013

Feb 14, 2013

Euro studies show flu vaccine working best against type B

(CIDRAP News) – New European studies reported today in Eurosurveillance suggest that this year's influenza vaccine is providing good protection against influenza B viruses but only moderate protection against type A—findings more or less consistent with earlier results in the United States.

Feb 08, 2013

Feb 08, 2013

US flu ebbs but still causes considerable illness

(CIDRAP News) – US flu indicators continued their decline last week, though many states are still reporting brisk levels of flu activity, the Centers for Disease Control and Prevention (CDC) reported today.

Jan 11, 2013

Jan 11, 2013

US flu activity shifts west as some national markers drop

(CIDRAP News) – Flu activity indicators showed some wobble last week, which might suggest that activity in the United States is starting to ebb in some locations or could reflect some artifacts of disease reporting that health officials sometimes see over the holiday period.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»